UNITY Shares Nearly Halved after Lead Asset Fails to Match Regeneron’s Eylea 3/27/2023

5 High-Paying Life Science Jobs that Don't Include Management 3/27/2023

BrainStorm Secures FDA Adcomm for ALS Therapy NurOwn 3/27/2023

Pharming’s Leniolisib Gains FDA Approval in Ultra-Rare Disease 3/27/2023

Relmada Looks to Rebound with New Protocol After Two Phase III Flops 3/27/2023

FDA Action Alert: Roche, Emergent and More 3/27/2023

Latest Data for Karuna’s Schizophrenia Drug Spark Investor Concern 3/24/2023

AbbVie Clinches Back-to-Back Clinical Wins in Ulcerative Colitis, Lupus 3/24/2023

NICE Backs PTC’s Gene Therapy for Ultra-Rare Pediatric Disease 3/24/2023

Sponsored: Inspirational Space Sparks Scientific Innovation at the First Life Sciences Building i... 3/24/2023

FDA Adcomm Backs Accelerated Approval of Biogen’s Tofersen in SOD1-ALS 3/23/2023

Dupixent Clears Phase III in Bid to Become First Biologic for COPD 3/23/2023

Cidara and Melinta Win FDA Approval for First New Echinocandin in a Decade 3/23/2023

Novo Nordisk Inks Deal with Dewpoint Therapeutics to Boost Diabetes Portfolio 3/23/2023

When Experience Becomes a Barrier: Ageism at Work 3/23/2023

Mid-Stage Win Gives 89Bio a Boost in NASH Race 3/22/2023

Pfizer-Backed Flare Seeks Transcription Factor Therapies with $123M Series B 3/22/2023

Gilead’s Yescarta Bests Long-Time Standard of Care in R/R LBCL Overall Survival 3/22/2023

Altimmune Obesity Drug Well-Positioned Despite Safety Data 3/22/2023

FDA's Marks Supports Accelerated Approval for Gene Therapies 3/21/2023